BioCardia announces allowance of Japanese patent for Heart3D Fusion Imaging software

BioCardia, Inc.

Japanese patent allowed for 'Target Site Selection, Entry, and Update with Automatic Remote Image Annotation'.
Patent protects Heart3D Fusion Imaging used for treatment planning and navigation during CardiAMP Cell Therapy procedures.
Claims cover transposing pre-op CT/MRI 3D images onto 2D orthogonal images to generate combined 3D model in sterile field.
Technology supports CardiAMP cell therapy for ischemic heart failure and Helix intramyocardial delivery system.
Company working on Japan PMDA submission and US regulatory discussions for these product candidates.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.